Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000756916 | SCV000884900 | likely benign | not provided | 2018-04-12 | criteria provided, single submitter | clinical testing | The c.2742T>C; p.Ala914Ala variant (rs753812144) does not alter the amino acid sequence of the WDR19 protein and computational splice site prediction algorithms do not predict a change in the nearest splice site or creation of a cryptic splice site. This variant has not been reported in association with skeletal dysplasias in medical literature or in gene specific variation databases. This variant is listed in the genome Aggregation Database (gnomAD) with an overall population frequency of 0.003% (identified on 8 out of 262,984 chromosomes). Based on the available information, the c.2742T>C variant is likely to be benign. |
Labcorp Genetics |
RCV001455522 | SCV001659284 | likely benign | Asphyxiating thoracic dystrophy 5; Senior-Loken syndrome 8 | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002485961 | SCV002796584 | likely benign | Asphyxiating thoracic dystrophy 5; Nephronophthisis 13; Cranioectodermal dysplasia 4; Senior-Loken syndrome 8; Spermatogenic failure 72 | 2022-04-06 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000756916 | SCV005257293 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004540080 | SCV004774231 | likely benign | WDR19-related disorder | 2019-07-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |